Company Profile

SHREE GANESH REMEDIES LTD.

NSE : NABSE : 540737ISIN CODE : INE414Y01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE401.90-1.45 (-0.36 % )
PREV CLOSE (Rs.) 403.35
OPEN PRICE (Rs.) 409.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 3368
TODAY'S LOW / HIGH (Rs.)399.00 409.95
52 WK LOW / HIGH (Rs.) 79.12 461.4
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.37
TTM EPS (Rs.) 9.75
P/E Ratio 41.23
Book Value (Rs.) 52.31
Face Value (Rs.) 10
MCap (Rs. in Mn) 4021.59
Price/Earning (TTM) 32.23
Price/Sales (TTM) 8.19
Price/Book (MRQ) 7.68
PAT Margin (%) 16.47
ROCE (%) 32.63
Incorporation Year : 1995

Management Info :

- Chairman Chandulal Manubhai Kothia - Managing Director

Registered Office :

Address : Plot No. 6011,G I D C, ,
Ankleshwar,
Gujarat-393002

Phone : 02641 22777

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
13Jul07-13-2021$Shree Ganesh Remedies informs about investor presentation Shree Ganesh Remedies inform

Pursuant to the applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Shree Ganesh Remedies has informed that Investor presentation have been uploaded on the website of the Company under ‘Investor Relations’. The Weblink of the same is attached.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the applicable provisions of SEBI (Listing Obligati..
01Jun06-01-2021$ Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015, Regarding Development Of New Product Announcement Under Regulati
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding Development of New Product
Announcement under Regulation 30 of SEBI (LODR) Regulations, 20..
27May05-27-2021$Shree Ganesh Remedies informs about announcement Shree Ganesh Remedies inform

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Remedies has informed that the company has successfully commissioned a new Plant No.3B at GIDC Ankleshwar, with an installed production capacity 54 KL (Kilo litres) working volumes for its existing products. The trial run of the plant was successfully completed on May 26, 2021 and the Company is expected to begin commercial production by early June, 2021. Further the commissioning of new Plant No.3B has been funded through internal accruals and the Company continues to be a 'Zero Debt Entity'.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
27May05-27-2021$ Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Announcement Under Regulati
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015
Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015
03May05-03-2021$Shree Ganesh Remedies board recommends final dividend Shree Ganesh Remedies board

Shree Ganesh Remedies has informed that the Board of Directors of the Company at its meeting held on May 03, 2021, has recommended Final Dividend of Rs 1.75 per Equity Share of Face Value of Rs 10 each for the Financial Year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remedies has informed that the Board of Directors..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit23.3797.5299999999999
Gross Profit 32.78 129.49
Operating Profit 41.63157.42
Net Sales 126.33490.82
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 19086.15 (4.92%)
M.Cap ( in Cr)
40556.74
Sanofi India (BSE)
 8367.90 (3.43%)
M.Cap ( in Cr)
19271.79
Alkem Laboratories (BSE)
 3454.55 (3.70%)
M.Cap ( in Cr)
41304.33
Sun Pharma Inds. (BSE)
 774.00 (10.06%)
M.Cap ( in Cr)
185708.53
Divi's Lab (BSE)
 4904.65 (1.20%)
M.Cap ( in Cr)
130203.05
Shareholding Pattern More
PROMOTERS 68.39 %
NON-INSTITUTION 31.61 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes